Expression of serum EBV-miR-BART13-3p and its diagnostic value in patients with chronic hepatitis B liver fibrosis in Qinghai, China

Expression of serum EBV-miR-BART13-3p and its diagnostic value in patients with chronic hepatitis B liver fibrosis in Qinghai, China

ObjectiveTo investigate the difference in the expression of serum EBV-miR-BART13-3p between chronic hepatitis B (CHB) patients with different liver fibrosis stages in Qinghai, China and the value of serum EBV-miR-BART13-3p in the diagnosis of CHB liver fibrosis. MethodsA total of 100 patients with C...

Full description

Bibliographic Details
Main Author:	LI Pingying
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2019-04-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=9738

Similar Items

The biological functions and regulatory mechanisms of EBV-encoded miR-BART9 and miR-BART18-5p in nasopharyngeal carcinoma
by: Chung Yuan Hsu, et al.
Published: (2014)

Study of ebv-miR-BART18-5p targets by proteomics approach
by: Chi Ting Lai, et al.
Published: (2009)

Functional analysis of ebv-miR-BART18-5p by systems biology approaches
by: Shih Cian Huang, et al.
Published: (2009)

Characterization of EBV Encoded MicroRNA miR-BART3 in Nasopharyngeal Carcinoma Cells
by: Yi An Tai, et al.
Published: (2013)

Functional characterization and target exploration of EBV-encoded microRNA ebv-mir-BART4
by: Ju Yin Tsao, et al.
Published: (2008)

Targeting the Ca2+ Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome
by: Alessia Gallo, et al.
Published: (2016-08-01)

EBV-miR-BART7-3p Imposes Stemness in Nasopharyngeal Carcinoma Cells by Suppressing SMAD7
by: Longmei Cai, et al.
Published: (2019-10-01)

Study the role of EBV encoded miRNA BART3 in NPC pathogenesis.
by: Chi Wen Hsu, et al.
Published: (2012)

miR-4721, Induced by EBV-miR-BART22, Targets GSK3β to Enhance the Tumorigenic Capacity of NPC through the WNT/β-catenin Pathway
by: ZiBo Tang, et al.
Published: (2020-12-01)

Value of microRNAs in diagnosis of chronic hepatitis B-related liver fibrosis
by: LI Pingying
Published: (2017-12-01)

miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis
by: Li Zhou, et al.
Published: (2018-03-01)

EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma.
by: Xiaoming Lyu, et al.
Published: (2018-12-01)

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
by: Valli De Re, et al.
Published: (2020-06-01)

Diagnostic Accuracy of Serum Hepatitis B Virus DNA Levels and ALT for Liver Fibrosis
by: Madeeha Nazar
Published: (2018-01-01)

Correction: EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma.
by: Xiaoming Lyu, et al.
Published: (2020-04-01)

EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways
by: Cheng Lin, et al.
Published: (2018-11-01)

The Oncogenic Role of miR-BART19-3p in Epstein-Barr Virus-Associated Diseases
by: Qingxun Zhang, et al.
Published: (2020-01-01)

Correction to: EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways
by: Cheng Lin, et al.
Published: (2019-01-01)

EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival.
by: Dong Kang, et al.
Published: (2015-06-01)

Diagnostics of the hepatic fibrosis and cirrhosis in children by means of serum markers
by: A N Surkov, et al.
Published: (2009-12-01)

Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients
by: Thorben Fründt, et al.
Published: (2021-05-01)

The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families.
by: Yoshiki Murakami, et al.
Published: (2011-01-01)

The Role of miR-29a in the Regulation, Function, and Signaling of Liver Fibrosis
by: Ying-Hsien Huang, et al.
Published: (2018-06-01)

Roles of Epstein-Barr virus-encoded miR-BART microRNAs in viral infection of nasopharyngeal epithelial cells
by: Yuen, Kit-san, et al.
Published: (2014)

Serum Exosomal miRNAs for Grading Hepatic Fibrosis Due to Schistosomiasis
by: Pengfei Cai, et al.
Published: (2020-05-01)

Diagnostic value of serum markers of fibrosis in chronic liver diseases
by: E V Vinnitskaia, et al.
Published: (2013-02-01)

miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression
by: Song Wei, et al.
Published: (2019-06-01)

Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells
by: Baconnais Sonia, et al.
Published: (2010-10-01)

EBV BART MicroRNAs Target Pro-apoptotic and Anti-Wnt Signaling Genes to Promote Cell Survival and Proliferation
by: Kang, Dong
Published: (2015)

Serum angiopoietin-2 as a noninvasive diagnostic marker of stages of liver fibrosis in chronic hepatitis C patients
by: Mohamed M Makhlouf, et al.
Published: (2016-01-01)

Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer
by: Hao Ding, et al.
Published: (2020-10-01)

Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
by: WangYu Zhu, et al.
Published: (2016-01-01)

Value of serum liver fibrosis markers in the diagnosis of liver fibrosis
by: ZHANG Yu
Published: (2019-11-01)

Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice
by: Fatemeh Momen-Heravi, et al.
Published: (2021-09-01)

Hepatic remodeling, serum biomarkers and prevention of fibrosis progression in liver disease.
by: Reichenbach Marinkovic, Vedrana
Published: (2012)

Diagnostic Value of Serum Markers of Liver Fibrosis in Patients with HCV-Infection
by: S.L. Melanich
Published: (2013-11-01)

Bart Syndrome
by: Dae Young Kim, et al.
Published: (2015-03-01)

Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
by: Simona Censi, et al.
Published: (2021-03-01)

Diagnostic possibilities of methods for the evaluation of liver fibrosis in chronic viral hepatitis
by: A N Navrotsky
Published: (2016-11-01)

Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis.
by: M L Arffa, et al.
Published: (2016-01-01)